Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genetics and proteomics in scleroderma.

Carol A Feghali-Bostwick1

  • 1Division of Pulmonary, Allergy, and Critical Care Medicine, Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease, Department of Medicine, 628 NW MUH, 3459 Fifth Ave, Pittsburgh, PA 15213, USA. feghalica@upmc.edu

Current Rheumatology Reports
|March 12, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transcriptomic characterization of lung pericytes in systemic sclerosis-associated pulmonary fibrosis.

iScience·2024
Same author

The Role of SOX9 in IGF-II-Mediated Pulmonary Fibrosis.

International journal of molecular sciences·2023
Same author

First Characterization of the Transcriptome of Lung Fibroblasts of SSc Patients and Healthy Donors of African Ancestry.

International journal of molecular sciences·2023
Same author

CXCL9 Links Skin Inflammation and Fibrosis through CXCR3-Dependent Upregulation of Col1a1 in Fibroblasts.

The Journal of investigative dermatology·2023
Same author

Antifibrotic factor KLF4 is repressed by the miR-10/TFAP2A/TBX5 axis in dermal fibroblasts: insights from twins discordant for systemic sclerosis.

Annals of the rheumatic diseases·2021
Same author

Systemic sclerosis biomarkers detection in the secretome of TGFβ1-activated primary human lung fibroblasts.

Journal of proteomics·2021
Same journal

Type I Interferonopathies: Fifteen Years On, From Concept to Therapeutic Perspectives.

Current rheumatology reports·2026
Same journal

Intensive Care Management of ANCA-associated Vasculitides: a Narrative Review.

Current rheumatology reports·2026
Same journal

The Role of Musculoskeletal Ultrasound in Psoriatic Arthritis: From Preclinical Detection to Treatment Monitoring.

Current rheumatology reports·2026
Same journal

Correction to: Is Gout and Autoinflammatory Disease?

Current rheumatology reports·2026
Same journal

Risks and Management of Glucocorticoid Therapy for Patients with Rheumatic Disease Having Surgery.

Current rheumatology reports·2026
Same journal

Perioperative Management Considerations for Patients with Systemic Lupus Erythematosus.

Current rheumatology reports·2026
See all related articles

Systemic sclerosis (SSc) pathogenesis remains unclear, but genetic factors play a role. Advanced technologies are revealing new insights for disease markers and therapies.

Area of Science:

  • Immunology
  • Genetics
  • Molecular Biology

Background:

  • Systemic sclerosis (SSc) pathogenesis is not fully understood.
  • Genetic, familial, and twin studies indicate a genetic predisposition to SSc.
  • SSc is a complex autoimmune disease affecting connective tissues.

Purpose of the Study:

  • To explore the underlying mechanisms of SSc pathogenesis.
  • To leverage recent technological advancements for SSc research.
  • To identify potential new biomarkers and therapeutic targets for SSc.

Main Methods:

  • Utilizing high-throughput technologies such as gene expression profiling.
  • Employing proteomic analyses to study SSc.
  • Analyzing genetic and familial data related to SSc.

Related Experiment Videos

Main Results:

  • High-throughput technologies are accelerating the discovery of SSc mechanisms.
  • New data provide insights into the molecular pathways of SSc.
  • Potential for identifying novel disease markers and therapeutic strategies.

Conclusions:

  • Recent technological advances are crucial for understanding SSc.
  • The findings pave the way for personalized medicine in SSc.
  • This research holds promise for improving SSc patient outcomes and other diseases.